Research Article | Open Access
The Methanolic Extract from Murraya koenigii L. Inhibits Glutamate-Induced Pain and Involves ATP-Sensitive K+ Channel as Antinociceptive Mechanism
Murraya koenigii L. is a perennial shrub, belonging to the family Rutaceae. Traditionally, the leaves of this plant are extensively used in treatment of a wide range of diseases and disorders including pain and inflammation. Although researchers have revealed the antinociceptive effects of this plant’s leaves during past few years, the mechanisms underlying these effects are still unknown. Therefore, the present study evaluated some antinociceptive mechanisms of the methanolic extract of M. koenigii (MEMK) leaves along with its antinociceptive potential using several animal models. The antinociceptive effects of MEMK were evaluated using formalin-induced licking and acetic acid-induced writhing tests at the doses of 50, 100, and 200 mg/kg. In addition, we also justified the possible participations of glutamatergic system and ATP-sensitive potassium channels in the observed activities. Our results demonstrated that MEMK significantly () inhibited the pain thresholds induced by formalin and acetic acid in a dose-dependent manner. MEMK also significantly () suppressed glutamate-induced pain. Moreover, pretreatment with glibenclamide (an ATP-sensitive potassium channel blocker) at 10 mg/kg significantly () reversed the MEMK-mediated antinociception. These revealed that MEMK might have the potential to interact with glutamatergic system and the ATP-sensitive potassium channels to exhibit its antinociceptive activities. Therefore, our results strongly support the antinociceptive effects of M. koenigii leaves and provide scientific basis of their analgesic uses in the traditional medicine.
Murraya koenigii L. Sprengel (family: Rutaceae) is a small and strong smelling perennial shrub that commonly grows in South East Asian countries and known as curry leaf plant. This plant is widely cultivated for its leaves which possess characteristic flavor and aroma and are used as a condiment and flavoring agent in ethnic foods [1, 2]. Traditionally, the leaves of this plant are used to treat a wide range of diseases and disorders such as pain, inflammation, itching, cancer, diabetes, and blood disorders [1, 3]. Previous phytochemical screening revealed a rich profile of simple phenolic acids including gallic, cinnamic, tannic, caffeic, ferulic, chlorogenic, and vanillic acids in curry leaves . The essential oils identified in these leaves include α-pinene, β-phellandrene, (E)-caryophyllene, α-selinene, tetradecanoic acid, hexadecanoic acid, c-eudesmol, a-muurolol, (Z,E)-farnesol, and (Z,Z)-farnesol . The leaves also contain monoterpene derived hydrocarbons and alcohols possessing antioxidant potentials in vitro . In 2013, the research groups of Nakamura and Ma isolated six new carbazole alkaloids including karapinchamines A and B , N-benzyl carbazole-A, N-benzyl carbazole-B, iso-koenidine, and iso-koenigine along with fourteen other known carbazole alkaloids having hepatoprotective and anticancer properties .
Along with this rich phytochemical profile, researchers also revealed the hypolipidemic, antidiabetic , hepatoprotective, antidiarrheal, and antioxidant properties  of curry leaves. Although their antinociceptive activity is well described [8, 9], the mechanisms of actions are not revealed yet. Therefore, for the first time, we evaluated the possible participations of glutamatergic system as well as ATP-sensitive K+ channels in methanolic extract of M. koenigii- (MEMK-) mediated antinociception in mice. In addition, we also justified the action of MEMK in two conventional pain models including acetic acid-induced writhing and formalin-induced licking tests.
2. Materials and Methods
2.1. Plant Material and Extraction
M. koenigii leaves were collected from Baily Road, Dhaka, Bangladesh, in April 2015. The samples were then identified by Busra Khan, Principle Scientific Officer, Bangladesh National Herbarium, with a voucher number of DACB: 41516. Powdered dried leaves (300 g) were macerated with 500 mL of methanol with occasional stirring for 72 hours at °C temperature. Then the collected filtrate was dried using rotary evaporator and normal air flow, respectively, resulting in 16.50 g of extract (yield: 5.50%). This crude extract was further used for the acute toxicity and antinociceptive activity analysis.
2.2. Drugs and Reagents
Diclofenac sodium and glibenclamide were purchased from Square Pharmaceuticals Ltd. (Dhaka, Bangladesh). Methanol, 99% dimethylsulfoxide (DMSO), l-glutamic acid, acetic acid, and formalin were procured from Merck (Darmstadt, Germany).
2.3. Phytochemical Screening
The crude methanolic extract of M. koenigii was qualitatively tested to detect the presence of alkaloids, glycosides, tannins, carbohydrates, reducing sugars, flavonoids, and saponins according to the standard protocols .
Male Swiss Albino mice of 20–25 g body weight were collected from the Animal Research Branch of the International Center for Diarrheal Disease and Research, Bangladesh (ICDDR,B). Animals were maintained under standard laboratory conditions (maintaining 12 h light/dark cycle, °C room temperature, and 55–65% relative humidity) with ICDDR,B formulated standard diet and clean water provided ad libitum. The animals were kept to the laboratory environment for a period of 14 days before the experiments and fasted overnight prior to the experiments. All experimental animals were treated following the Ethical Principles and Guidelines for Scientific Experiments on Animals (1995) formulated by The Swiss Academy of Medical Sciences and the Swiss Academy of Sciences. All protocols conducted in this study were approved by the Institutional Ethics Committee of Stamford University Bangladesh (SUB/IAEC/15.07).
2.5. Drugs and Treatments
Diclofenac sodium (10 mg/kg) was administered intraperitoneally (i.p.) 15 min before the nociceptive stimuli. In all experiments, DMSO (vehicle, 0.1 mL/mouse) or MEMK (50, 100, and 200 mg/kg) were administered orally 30 min prior to the induction of nociception. Moreover, glibenclamide at the dose of 10 mg/kg was given 15 min prior to the standard drug in addition to MEMK to justify the possible involvement of K+ channel.
2.6. Acute Toxicity Test
The animals were divided into desired groups, with each group containing five to seven animals. MEMK was administered to the animals at the doses of 1000, 2000, and 3000 mg/kg p.o. and animals were observed for any allergic reaction or mortality for next 72 h. In the meantime, they were allowed free access of food and water ad libitum .
2.7. Formalin-Induced Nociception
The procedure used was similar to that previously described by Santos and Calixto . Animals were randomly selected for each group and pretreated with standard drug or MEMK. 60 min after MEMK and 30 min after drug, 20 μL of 2.5% formalin was injected in the ventral surface of the right hind paw of the mice. Then the animals were observed and numbers of lickings and bitings of the injected paw were recorded for 0–5th min (neurogenic or early phase) and 15–30th min period (inflammatory or late phase) after formalin injection.
2.8. Acetic Acid-Induced Writhing Test
Nociception in mice was induced with intraperitoneal injection of 0.6% acetic acid (10 mL/kg) 15 min after the drug and 30 min after MEMK treatments. 5 min after the acetic acid injection, mice were observed and the total number of writhings (abdominal constriction and stretching of hind limb) was counted for 30 min .
2.9. Glutamate-Induced Nociception
In glutamate test, mice were treated with extract or standard drug as mentioned above. 30 min after extract and 15 min after drug, 20 μL of glutamate (10 μM/paw) was injected in the subplantar region of the right hind paw of mice. Mice were then observed for 15 min and numbers of lickings and bitings of the injected paw were counted as a score of nociception .
2.10. Involvement of ATP-Sensitive K+ Channel Pathway
The possible involvement of ATP-sensitive K+ channel in MEMK-mediated antinociceptive effect was evaluated using previously described methods by Mohamad et al. and Perimal et al. [15, 16]. 15 min before the treatment with MEMK (200 mg/kg), animals were treated with glibenclamide (10 mg/kg). Following 30 min of MEMK administration, animals were challenged with i.p. injection of 0.6% acetic acid and immediately placed in a chamber. Then the number of writhings was recorded for 30 min, starting from 5 min after injection.
2.11. Statistical Analysis
The results are expressed as mean ± SEM. The statistical analysis was performed using one-way analysis of variance (ANOVA) followed by Dunnett’s post hoc test using SPSS software. ED50 values were calculated using GraphPad Prism and figures were drawn using SigmaPlot software.
3. Results and Discussion
The present study evaluated the actions of MEMK on different animal models of pain such as formalin-induced licking and acetic acid-induced writhing tests. This study also revealed the probable underlying mechanisms including involvement of glutamatergic system as well as ATP-sensitive K+ channels in the antinociceptive activities of MEMK. Moreover, our study demonstrated that oral administration of MEMK at 1000–3000 mg/kg doses did not produce any allergic reactions, abnormal behavior, and mortality of the animals within 72 h of observation period, revealing its nontoxic profile within our experimental doses tested up to 3000 mg/kg.
It is well established that the neurogenic pain in first phase of formalin test is mediated through the activation of substance P and bradykinins. On the other hand, several amines including histamine and serotonin, bradykinins, and prostaglandins were reported to play a critical role in the late phase to produce inflammatory pain . Our results demonstrated that the acute administration of MEMK significantly () suppressed the licking behavior of the animals in both phases of formalin test. The percentages of licking inhibitions were calculated as 15.66, 40.38, and 59.06 in first phase and 10.90, 53.90, and 80.27 in late phase for the doses of 50, 100, and 200 mg/kg, respectively (Figures 1(a) and 1(b)). ED50 values were also calculated as 146.40 mg/kg for first phase and 100.70 mg/kg for the late phases. A previously published work reported by Gupta et al.  supports these findings, where they found that the aqueous extract of M. koenigii at the doses of 400 and 800 mg/kg inhibited formalin-induced pain in mice. In addition, the intraperitoneal injection of acetic acid causes pH imbalance and the activation of peritoneal resident cells (macrophages and mast cells). This influences an elevated release of several inflammatory mediators such as prostaglandin E2 and TNF- . As depicted in Figure 2, the results demonstrated that all doses of MEMK significantly () inhibited acetic acid-induced writhing with ED50 value of 77.85 mg/kg. The percentages of writhing inhibitions were calculated as 33.85, 60.22, and 78.68 for 50, 100, and 200 mg/kg doses, respectively. Moreover, the petroleum ether extract and the alkaloid fraction of M. koenigii leaves were also previously reported to have writhing inhibitory properties in animals [9, 18]. Therefore, our findings and previously reported works strongly support the fact that MEMK is endowed with formalin-induced and acetic acid-induced pain inhibitory properties.
In order to elucidate the antinociceptive mechanism of action of MEMK, the nociception induced by intraplantar injection of glutamate was tested. Glutamate is an excitatory amino acid widely known to play major role in pain perceptions by acting through peripheral, spinal, and supraspinal sites of actions using both N-methyl-D-aspartate (NMDA) and non-NMDA receptors . Additionally, glutamate is also reported to induce the synthesis and release of several proinflammatory mediators including nitric oxide (NO) and NO-related and arachidonic acid-related substances in both central and peripheral nervous systems . We found that MEMK significantly () inhibited the noxious stimuli induced by glutamate in a dose-dependent manner. The estimated percentages of inhibitions were 48.44, 69.53, and 85.94 for 50, 100, and 200 mg/kg doses, respectively (ED50: 52.76 mg/kg). Besides, the reference drug diclofenac sodium also significantly () reduced the pain behavior of the animals accounting for 79.30% of licking inhibition (Figure 3). Considering the above findings, it is conceivable that the components of MEMK might have the potential to interact with glutamatergic system to demonstrate its antinociceptive activity. Moreover, it was also found that administration of glibenclamide (an ATP-sensitive potassium channel antagonist) at 10 mg/kg alone did not alter the writhing episodes evoked by the injection of 0.6% acetic acid. However, given together with the extract, glibenclamide significantly () reversed the antinociceptive effects of MEMK (Figure 4). Substantial scientific reports revealed that glibenclamide specifically blocks only the ATP-sensitive K+ channels but does not affect other types like Ca2+ activated and voltage-gated K+ channels . Therefore, the results might suggest that MEMK involves the opening of ATP-sensitive potassium channels which allows the efflux of K+ ion, leading to repolarization or hyperpolarization of the membrane, which reduces the membrane excitability .
Our preliminary phytochemical analysis revealed the presence of alkaloids, glycosides, tannins, carbohydrates, reducing sugars, and flavonoids in MEMK (Table 1). It has been reported that the carbazole alkaloids as well as the flavonoids isolated from curry leaves possess potent antioxidant properties [1, 20, 21]. Moreover, the chemical compounds with antioxidant properties are generally known to relieve pain through the prevention of lipid peroxidation as well as the synthesis and release of different inflammatory mediators . Therefore, it is conceivable that the phytochemicals present in the extract participate at least in a part of the observed activities of MEMK.
In conclusion, the results of the present study demonstrated the antinociceptive actions of the methanolic extract of M. koenigii leaves and provided the scientific evidence regarding their traditional uses as an analgesic agent. This study also uncovered the probable participation of glutamatergic system as well as ATP-sensitive potassium channels in MEMK-mediated antinociception.
The present address for Md. Moniruzzaman is Centre for Pain Research, Institute for Molecular Bioscience, the University of Queensland, Brisbane, QLD 4072, Australia.
The authors wish to confirm that there are no known competing interests associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.
Nushrat Sharmin Ani and Sudip Chakraborty contributed equally to this work.
The authors are grateful to Professor Dr. Bidyut Kanti Datta, Chairman, Stamford University Bangladesh, for his permission to use the laboratory facilities.
- A. P. Singh, T. Wilson, D. Luthria et al., “LC-MS-MS characterisation of curry leaf flavonols and antioxidant activity,” Food Chemistry, vol. 127, no. 1, pp. 80–85, 2011.
- M. Z. Gul, V. Attuluri, I. A. Qureshi, and I. A. Ghazi, “Antioxidant and α-glucosidase inhibitory activities of Murraya koenigii leaf extracts,” Pharmacognosy Journal, vol. 4, no. 32, pp. 65–72, 2012.
- A. Kumar, N. Shweta, and P. Giri, “Advance review on phytochemistry, pharmacology, antimicrobial, and clinical activities of an antidiabetic plant (Murraya koeingii L.),” International Journal of Innovative Research and Review, vol. 3, no. 1, pp. 60–87, 2015.
- B. R. R. Rao, D. K. Rajput, and G. R. Mallavarapu, “Chemical diversity in curry leaf (Murraya koenigii) essential oils,” Food Chemistry, vol. 126, no. 3, pp. 989–994, 2011.
- A. K. Biswas, M. K. Chatli, and J. Sahoo, “Antioxidant potential of curry (Murraya koenigii L.) and mint (Mentha spicata) leaf extracts and their effect on colour and oxidative stability of raw ground pork meat during refrigeration storage,” Food Chemistry, vol. 133, no. 2, pp. 467–472, 2012.
- S. Nakamura, S. Nakashima, Y. Oda et al., “Alkaloids from Sri Lankan curry-leaf (Murraya koenigii) display melanogenesis inhibitory activity: Structures of karapinchamines A and B,” Bioorganic and Medicinal Chemistry, vol. 21, no. 5, pp. 1043–1049, 2013.
- Q. Ma, J. Tian, J. Yang et al., “Bioactive carbazole alkaloids from Murraya koenigii (L.) Spreng,” Fitoterapia, vol. 87, no. 1, pp. 1–6, 2013.
- S. Gupta, M. George, M. Singhal, G. Sharma, and V. Garg, “Leaves extract of Murraya Koenigii linn for anti-inflammatory and analgesic activity in animal models,” Journal of Advanced Pharmaceutical Technology and Research, vol. 1, no. 1, pp. 68–77, 2010.
- R. A. Patil, P. M. Langade, P. B. Dighade, and Y. A. Hiray, “Antinociceptive activity of acute and chronic administration of Murraya koenigii L. leaves in experimental animal models,” Indian Journal of Pharmacology, vol. 44, no. 1, pp. 15–19, 2012.
- A. Ghani, Medicinal Plants of Bangladesh with Chemical Constituents and Uses, Asiatic Society of Bangladesh, Dhaka, Bangladesh, 2003.
- C. I. B. Walker, G. Trevisan, M. F. Rossato et al., “Antinociceptive activity of Mirabilis jalapa in mice,” Journal of Ethnopharmacology, vol. 120, no. 2, pp. 169–175, 2008.
- A. R. S. Santos and J. B. Calixto, “Further evidence for the involvement of tachykinin receptor subtypes in formalin, and capsaicin models of pain in mice,” Neuropeptides, vol. 31, no. 4, pp. 381–389, 1997.
- M. R. Sulaiman, T. A. S. Tengku Mohamad, W. M. Shaik Mossadeq et al., “Antinociceptive activity of the essential oil of zingiber zerumbet,” Planta Medica, vol. 76, no. 2, pp. 107–112, 2010.
- A. Beirith, A. R. S. Santos, and J. B. Calixto, “Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw,” Brain Research, vol. 924, no. 2, pp. 219–228, 2002.
- A. S. Mohamad, M. N. Akhtar, S. I. Khalivulla et al., “Possible participation of nitric oxide/cyclic guanosine monophosphate/protein kinase C/ATP-sensitive K + channels pathway in the systemic antinociception of flavokawin B,” Basic and Clinical Pharmacology and Toxicology, vol. 108, no. 6, pp. 400–405, 2011.
- E. K. Perimal, M. N. Akhtar, A. S. Mohamad et al., “Zerumbone-induced antinociception: involvement of the L-arginine-nitric oxide-cGMP-PKC-K+ATP channel pathways,” Basic and Clinical Pharmacology and Toxicology, vol. 108, no. 3, pp. 155–162, 2011.
- R. Gupta, L. K. Gupta, and S. K. Bhattacharya, “Naloxone blocks the beneficial effects of aqueous extract of Murraya koenigii (L.) Spreng leaves in models of pain,” European Review for Medical and Pharmacological Sciences, vol. 17, no. 13, pp. 1748–1751, 2013.
- B. Brar, J. S. Duhan, and P. Rakha, “Analgesic activity of various extracts of leaves of Murraya koenigii (L) spreng,” World Journal of Pharmacy and Pharmaceutical Sciences, vol. 4, no. 10, pp. 1255–1262, 2015.
- M. E. Fundytus, “Glutamate receptors and nociception: implications for the drug treatment of pain,” CNS Drugs, vol. 15, no. 1, pp. 29–58, 2001.
- M. B. Ningappa, R. Dinesha, and L. Srinivas, “Antioxidant and free radical scavenging activities of polyphenol-enriched curry leaf (Murraya koenigii L.) extracts,” Food Chemistry, vol. 106, no. 2, pp. 720–728, 2008.
- Q. G. Ma, K. Xu, Z. P. Sang et al., “Alkenes with antioxidative activities from Murraya koenigii (L.) Spreng,” Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 3, pp. 799–803, 2016.
- Md. K. Islam, N. N. Biswas, S. Saha et al., “Antinociceptive and antioxidant activity of Zanthoxylum budrunga wall (rutaceae) seeds,” The Scientific World Journal, vol. 2014, Article ID 869537, 7 pages, 2014.
Copyright © 2016 Nushrat Sharmin Ani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.